Guided Therapeutics (OTCMKTS:GTHP) Releases Quarterly Earnings Results

Guided Therapeutics (OTCMKTS:GTHP) posted its earnings results on Thursday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports. The company had revenue of $0.06 million for the quarter.

Guided Therapeutics Trading Down 5.3%

GTHP traded down $0.01 during trading on Friday, hitting $0.23. 1,120 shares of the company’s stock were exchanged, compared to its average volume of 13,155. Guided Therapeutics has a 1 year low of $0.06 and a 1 year high of $0.32. The stock has a 50 day moving average price of $0.26 and a 200 day moving average price of $0.22. The firm has a market cap of $18.81 million, a P/E ratio of -4.50 and a beta of 0.38.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.